Clinical Report: Quantitative UTE-MRI of Femoral Trabecular Bone
Overview
This prospective, single-center study investigated quantitative three-dimensional ultrashort echo-time (UTE) MRI for characterizing proximal femoral trabecular bone in adult female volunteers. The supplied article excerpt describes the rationale, recruitment, and cohort but does not provide the imaging results or numerical comparisons, so study findings cannot be summarized beyond its stated aims and methods.
Background
DXA is the clinical gold standard for osteoporosis assessment, but it provides two-dimensional areal BMD and does not directly depict three-dimensional trabecular architecture. QCT measures volumetric BMD but uses ionizing radiation and does not directly characterize marrow water and fat. UTE-MRI can acquire signal from bone with short T2 relaxation times and avoids ionizing radiation, although high-resolution trabecular imaging is technically constrained by motion sensitivity and limited field of view. The study focuses on the proximal femur, where trabecular bone is metabolically active and is a frequent site of fragility fracture.
Data Highlights
Study characteristic
Reported information
Design and setting
Prospective, single-center study conducted January 2022 through September 2025
Participants recruited
106 adult female volunteers; mean age 56.7 years (range 20–93)
Final cohort
92 participants; mean age 57.9 years (range 20–83)
Exclusions
Incomplete femoral-head coverage (n=5), potentially compromising artifacts (n=5), and missing imaging data due to storage failure (n=4)
Study objective
Apply quantitative three-dimensional UTE-MRI to assess proximal femoral trabecular bone
Key Findings
The study rationale identifies limitations of DXA for direct assessment of three-dimensional trabecular architecture.
The article describes QCT as providing volumetric BMD while involving ionizing radiation and not directly characterizing marrow water and fat.
UTE-MRI is presented as a method that permits direct imaging of bone and concurrent assessment of adjacent soft tissues.
The authors identify high spatial-resolution requirements, motion sensitivity, and restricted field of view as technical challenges for trabecular UTE-MRI.
The final study cohort comprised 92 adult female volunteers after 14 exclusions from the 106 initially recruited.
The supplied excerpt does not report quantitative imaging outcomes, group comparisons, or associations with DXA; no efficacy or diagnostic-performance finding can therefore be stated.
Clinical Implications
The supplied material describes UTE-MRI as an investigational approach to radiation-free characterization of proximal femoral trabecular bone, not as an established diagnostic test. Current screening and diagnostic guidance cited in the web context remains anchored to DXA, with QCT recognized in selected contexts; the excerpt provides no evidence to support replacing these methods with UTE-MRI.
Conclusion
The study addresses the potential of quantitative UTE-MRI to characterize proximal femoral trabecular bone, an area less studied than cortical bone. Because the provided article text omits the study’s results, its diagnostic or clinical value cannot be determined from the available material.
